Literature DB >> 17205349

Sacral chordoma: a diagnosis not to be sat on?

Lee Jeys1, Ruth Gibbins, Guy Evans, Robert Grimer.   

Abstract

Sacral chordomas are rare, slow-growing tumours that are amenable to surgery, but unfortunately often diagnosed late. The aim of the study was to identify presenting symptoms, which may aid diagnosis and reduce the treatment time. Forty-four patients were identified with sacral chordoma between 1989 and 2006. Clinical and pathological records were reviewed retrospectively to elicit the symptoms recorded prior to diagnosis, duration of symptoms, surgical treatment, size of tumour and survival. Eleven patients were excluded, leaving 33 patients in the study group. Thirty-one patients had chordomas arising from the sacrum and two patients from the coccyx. The mean duration of symptoms prior to diagnosis was 120 weeks (2.3 years), with a median of length of 104 weeks (two years) and range of 26 to 416 weeks (0.5 to eight years). The mean maximum tumour size at resection was 8.3 cm, with a mean volume of 614 cm(3) (range 9-2,113 cm(3)). Pain, typically dull and worse with sitting, was the most common presenting symptom in 85% of patients. The classic symptoms of cauda equina (saddle anaesthesia, bladder or bowel dysfunction) occurred in 70% patients (23 patients). Sacral chordoma should be considered in cases of back pain with coccydynia, especially with neurological symptoms.

Entities:  

Mesh:

Year:  2007        PMID: 17205349      PMCID: PMC2269011          DOI: 10.1007/s00264-006-0296-3

Source DB:  PubMed          Journal:  Int Orthop        ISSN: 0341-2695            Impact factor:   3.075


  3 in total

1.  Chordoma: incidence and survival patterns in the United States, 1973-1995.

Authors:  M L McMaster; A M Goldstein; C M Bromley; N Ishibe; D M Parry
Journal:  Cancer Causes Control       Date:  2001-01       Impact factor: 2.506

Review 2.  Diagnosis and treatment of low back pain.

Authors:  B W Koes; M W van Tulder; S Thomas
Journal:  BMJ       Date:  2006-06-17

3.  Chordoma: natural history and results in 28 patients treated at a single institution.

Authors:  D Baratti; A Gronchi; E Pennacchioli; L Lozza; M Colecchia; M Fiore; M Santinami
Journal:  Ann Surg Oncol       Date:  2003-04       Impact factor: 5.344

  3 in total
  9 in total

1.  Coccydynia (coccyx pain) caused by chordoma.

Authors:  Patrick M Foye
Journal:  Int Orthop       Date:  2007-03-23       Impact factor: 3.075

2.  Sacral chordoma: challenging for resection margin.

Authors:  Seung-Hyun Lee; Byung-Kwon Ahn
Journal:  Ann Coloproctol       Date:  2014-06

3.  Sacral chordoma: management of a rare disease in a tertiary hospital.

Authors:  Gada Housari; Mariana González; Purificación Calero; Rafael Beni; Eduardo Lobo
Journal:  Clin Transl Oncol       Date:  2012-08-03       Impact factor: 3.405

Review 4.  Sacral chordoma : A review of literature.

Authors:  S Pillai; S Govender
Journal:  J Orthop       Date:  2018-05-02

Review 5.  Left to themselves: Time to target chronic pain in childhood rare diseases.

Authors:  Christine B Sieberg; Alyssa Lebel; Erin Silliman; Scott Holmes; David Borsook; Igor Elman
Journal:  Neurosci Biobehav Rev       Date:  2021-03-24       Impact factor: 8.989

6.  Pudendal Neuralgia as the Initial Manifestation of Infiltrative Sacrococcygeal Chordoma.

Authors:  Sira Carrasco García de León; José Manuel Flores Barragán; Natalia Villasanti Rivas
Journal:  Case Rep Neurol       Date:  2016-08-31

7.  Risk Factors Associated with Reconstructive Complications Following Sacrectomy.

Authors:  Emma D Vartanian; Jeremy V Lynn; David P Perrault; Erik M Wolfswinkel; Andreas M Kaiser; Ketan M Patel; Joseph N Carey; Patrick C Hsieh; Alex K Wong
Journal:  Plast Reconstr Surg Glob Open       Date:  2018-11-05

8.  Giant sacrococcygeal chordoma: A case report.

Authors:  Qiang Xu; Houyun Gu; Xuqiang Liu; Hucheng Liu; Yibiao Zhou; Guiping Chen; Min Dai; Bin Zhang
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.889

9.  HOXA7, HOXA9, and HOXA10 are differentially expressed in clival and sacral chordomas.

Authors:  Daniela Jäger; Thomas F E Barth; Silke Brüderlein; Angelika Scheuerle; Beate Rinner; Adrian von Witzleben; André Lechel; Patrick Meyer; Regine Mayer-Steinacker; Alexandra von Baer; Markus Schultheiss; Christian R Wirtz; Peter Möller; Kevin Mellert
Journal:  Sci Rep       Date:  2017-05-17       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.